Cormorant Asset Management, LP Rhythm Pharmaceuticals, Inc. Transaction History
Cormorant Asset Management, LP
- $1.43 Billion
- Q3 2024
A detailed history of Cormorant Asset Management, LP transactions in Rhythm Pharmaceuticals, Inc. stock. As of the latest transaction made, Cormorant Asset Management, LP holds 400,000 shares of RYTM stock, worth $24.8 Million. This represents 1.47% of its overall portfolio holdings.
Number of Shares
400,000
Previous 475,000
15.79%
Holding current value
$24.8 Million
Previous $19.5 Million
7.45%
% of portfolio
1.47%
Previous 1.5%
Shares
5 transactions
Others Institutions Holding RYTM
# of Institutions
192Shares Held
67.3MCall Options Held
834KPut Options Held
78.6K-
Primecap Management CO Pasadena, CA7.22MShares$448 Million0.28% of portfolio
-
Black Rock Inc. New York, NY6.74MShares$418 Million0.01% of portfolio
-
Baker Bros. Advisors LP New York, NY6.4MShares$397 Million3.59% of portfolio
-
Ra Capital Management, L.P. Boston, MA6.08MShares$377 Million4.44% of portfolio
-
Goldman Sachs Group Inc New York, NY3.88MShares$241 Million0.03% of portfolio
About RHYTHM PHARMACEUTICALS, INC.
- Ticker RYTM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 55,720,000
- Market Cap $3.46B
- Description
- Rhythm Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of rare genetic diseases of obesity. The company's lead product candidate is IMCIVREE, a potent melanocortin-4 receptor for the treatment of pro-opiomelanocortin (POMC), proprotein convert...